Translation of the efficacy of antibody-drug conjugates from preclinical to clinical using a semimechanistic PK/PD model: A case study with RC88
Abstract Three semimechanistic pharmacokinetic/pharmacodynamic (PK/PD) models, Simeoni, Jumbe, and Hybrid, were used for the efficacy translation of RC88 from preclinical to clinical. RC88 is a mesothelin‐targeting antibody-drug conjugate for malignant solid tumor. In the preclinical study, the rela...
Saved in:
Main Authors: | Qiaoning Li (Author), Ling Wang (Author), Jinfeng Zhang (Author), Guorui Zhao (Author), Zhihao Liu (Author), Xinting Ma (Author), Jing Jiang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PK/PD analysis of trazodone and gabapentin in neuropathic pain rodent models: Translational PK‐PD modeling from nonclinical to clinical development
by: Laura Oggianu, et al.
Published: (2023) -
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's disease
by: Peter Bloomingdale, et al.
Published: (2022) -
Comparing Model Performance in Characterizing the PK/PD of the Anti‐Myostatin Antibody Domagrozumab
by: Abhinav Tiwari, et al.
Published: (2020) -
Translational PK/PD for the Development of Novel Antibiotics-A Drug Developer's Perspective
by: Caterina Bissantz, et al.
Published: (2024) -
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
by: Marilia Barreca, et al.
Published: (2022)